Results 271 to 280 of about 993,013 (333)

Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance. [PDF]

Cancers (Basel)
Gawi Ermi A, Sarkar D.
europepmc   +1 more source

New Hepatocellular Carcinoma (HCC) Primary Cell Cultures as Models for Exploring Personalized Anti-TGF-β Therapies Based on Tumor Characteristics. [PDF]

Int J Mol Sci
Scialpi R, Espinosa-Sotelo R, Bertran E, Dituri F, Giannelli G, Fabregat I.   +5 more
europepmc   +1 more source

The Influence of Diet and Its Components on the Development and Prevention of Hepatocellular Carcinoma (HCC). [PDF]

Cancers (Basel)
Janota B, Szymanek B.
europepmc   +1 more source

Sporadic Hepatocellular Carcinoma in an Adolescent Harboring a Somatic CDH1 Mutation: A Case Report and Literature Review

The Kaohsiung Journal of Medical Sciences, EarlyView.
Chang‐Wei Su, Peir‐In Liang, Shih‐Chang Chuang   +2 more
wiley   +1 more source

Mitochondrial single-stranded DNA binding protein 1 (SSBP1) high expression as a potential biomarker and association with poor prognosis in hepatocellular carcinoma (HCC). [PDF]

Transl Cancer Res
Lin YR, Li JK, Yang X, Dong BR, Liu RA, Wang XM, Yu M, Xiong W.   +7 more
europepmc   +1 more source

Prostate-Specific Membrane Antigen (PSMA) PET/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Hannah N, Yu C, Nedumannil L, Haridy J, Kong G, Boussioutas A, Sood S.   +6 more
europepmc   +1 more source

Bulky Isolated Adrenal Metastasis as First Presentation of Occult Hepatocellular Carcinoma (HCC) in a Patient with a Synchronous Squamous Carcinoma of the Tongue.

Endocr Metab Immune Disord Drug Targets
Lodin M, Ragni A, Renzelli V, Rossi M, Traverso ES, Gallo M.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hepatocellular carcinoma (HCC): an update.

Seminars in Oncology, 2007
In the absence of large randomized trials, the current treatment strategy for hepatocellular carcinoma (HCC) remains a matter of choice depending mostly on retrospective studies, experience of centers, and the technical therapeutic possibilities. In fact, treatment decisions must be based on HCC extension and liver function, which is dependent on ...
P. Rougier, E. Mitry, J. Barbare, J. Taieb   +3 more
semanticscholar   +3 more sources

Hepatocellular Carcinoma (HCC)

, 2008
Hepatocellular carcinoma (HCC) is considered to be one of the most common malignancies worldwide, and the most common one in Africa and Asia. Over the last decade, a rising incidence of up to 10–15/100,000 per population has been seen in the Western world, with an estimate of 250,000 deaths and more than a million worldwide per year.
T. Helmberger
semanticscholar   +2 more sources

Hepatocellular carcinoma (HCC)

, 2009
Hepatocellular ...
A. Jibawi, D. Cade
semanticscholar   +2 more sources